A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma

A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma

<i>Background and Objectives:</i> The clinical prognosis and survival prediction of glioma based on gene signatures derived from heterogeneous tumor cells are unsatisfactory. This study aimed to construct an immune gene-related prognostic score model to predict the prognosis of glioma an...

Full description

Bibliographic Details
Main Authors:	Xuehui Luo, Qi Wang, Hanmin Tang, Yuetong Chen, Xinyue Li, Jie Chen, Xinyue Zhang, Yuesen Li, Jiahao Sun, Suxia Han
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Medicina
Subjects:	RNA sequencing immune-related gene prognostic biomarker glioma immune checkpoint blockade tumor immune microenvironment
Online Access:	https://www.mdpi.com/1648-9144/59/1/23

Similar Items

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
by: Qi Wang, et al.
Published: (2022-05-01)

Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
by: Rachel L. Y. Ho, et al.
Published: (2021-07-01)

DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
by: Mu Chen, et al.
Published: (2022-05-01)

Radiotherapy combined with anti-CEACAM1 immunotherapy to induce survival advantage in glioma
by: Jinhu Li, et al.
Published: (2023-03-01)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
by: Hua Zhu, et al.
Published: (2022-07-01)

A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma
by: Ying-Shi Yuan, et al.
Published: (2022-10-01)

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
by: Zhirui Zeng, et al.
Published: (2022-09-01)

Tumor microenvironment and immunotherapy of oral cancer
by: Chang Liu, et al.
Published: (2022-10-01)

TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis
by: Bingcheng Wang, et al.
Published: (2024-01-01)

Multi-omics analysis reveals CLIC1 as a therapeutic vulnerability of gliomas
by: Chengcheng Wang, et al.
Published: (2023-11-01)

Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
by: Yujia Chen, et al.
Published: (2023-01-01)

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas
by: Siliang Chen, et al.
Published: (2022-11-01)

Identification of a Novel Epithelial–Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
by: Tianyuan Ruan, et al.
Published: (2022-01-01)

Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas
by: Jinchao Wang, et al.
Published: (2023-05-01)

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
by: Soumaya Rafii, et al.
Published: (2023-05-01)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
by: Liang Huang, et al.
Published: (2022-09-01)

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma
by: Pu Wu, et al.
Published: (2022-10-01)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
by: Huan Zhang, et al.
Published: (2023-01-01)

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
by: Xiaoyue Ren, et al.
Published: (2023-08-01)

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
by: Hinda Najem, et al.
Published: (2021-08-01)

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma
by: Jinna Li, et al.
Published: (2023-08-01)

Unveiling the landscape of cytokine research in glioma immunotherapy: a scientometrics analysis
by: Hongyu Zhang, et al.
Published: (2024-01-01)

Targeting FGL2 in glioma immunosuppression and malignant progression
by: Xiaoyu Ma, et al.
Published: (2022-10-01)

Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion
by: Fei Li, et al.
Published: (2024-01-01)

Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma
by: Di Chen, et al.
Published: (2023-12-01)

A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma
by: Jia Chen, et al.
Published: (2023-02-01)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
by: Shenghua Zhuo, et al.
Published: (2023-12-01)

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma
by: Zhongqing Liang, et al.
Published: (2022-12-01)

Research Progress in Immunotherapy of Gliomas
by: Zhi-hong Duan, et al.
Published: (2023-08-01)

Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade
by: Alexander Chi, et al.
Published: (2021-06-01)

Targeting the Molecular and Immunologic Features of Leiomyosarcoma
by: Brandon M. Cope, et al.
Published: (2023-03-01)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
by: Wenchang Lv, et al.
Published: (2022-08-01)

Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification
by: Zesheng Peng, et al.
Published: (2023-03-01)

Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure
by: Lorenzo Castagnoli, et al.
Published: (2020-02-01)

Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value
by: Hua-Bao Cai, et al.
Published: (2024-01-01)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
by: Jiawei Dong, et al.
Published: (2023-01-01)

Comprehensive Analysis of Pyroptosis-Associated in Molecular Classification, Immunity and Prognostic of Glioma
by: Peng Chen, et al.
Published: (2022-01-01)

Microfibrillar-associated protein 2 is a prognostic marker that correlates with the immune microenvironment in glioma
by: Wanzhen Xu, et al.
Published: (2022-09-01)

PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
by: Peng Li, et al.
Published: (2022-06-01)

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
by: Chunyu Zhang, et al.
Published: (2022-08-01)